Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A A Geldof

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Cellular Immunology|January 1, 1980
T-cell differentiation in lethally irradiated and reconstituted miceG Kraal, A A Geldof, D Boden
Journal of Neuro-Oncology|April 2, 1998
Vinca-alkaloid neurotoxicity measured using an in vitro modelA A Geldof, A Minneboo, J J Heimans
Urological Research|January 1, 1992
Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasiaA A Geldof, C Engel, B R Rao
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1983
Histology of the bone marrow antibody response. An immunocytochemical study during the secondary response in mouse and ratA A Geldof, G F Rimmelzwaan, H L Langevoort
Anticancer Research|July 1, 1986
Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cellsA A Geldof, B R Rao, H J de Voogt
Urological Research|January 1, 1989
High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLuA A Geldof, H J De Voogt, B R Rao
Progress in Clinical and Biological Research|January 1, 1989
How to define hormone-resistanceH J de Voogt, R B Rao, A A Geldof
The Prostate|January 1, 1987
Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H)A A Geldof, H J de Voogt, B R Rao
Urological Research|January 1, 1987
Development of an in vivo clonogenic cell assay for rat prostate metastatic tumor--R3327-MatLyLuA A Geldof, B R Rao, H J de Voogt
Anticancer Research|August 6, 2000
Cell cycle arrest and clonogenic tumor cell kill by divergent chemotherapeutic drugsS C Mastbergen, I Duivenvoorden, R T Versteegh, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Cellular Immunology|January 1, 1980
T-cell differentiation in lethally irradiated and reconstituted miceG Kraal, A A Geldof, D Boden
Journal of Neuro-Oncology|April 2, 1998
Vinca-alkaloid neurotoxicity measured using an in vitro modelA A Geldof, A Minneboo, J J Heimans
Urological Research|January 1, 1992
Estrogenic action of commonly used fragrant agent citral induces prostatic hyperplasiaA A Geldof, C Engel, B R Rao
Virchows Archiv. B, Cell Pathology Including Molecular Pathology|January 1, 1983
Histology of the bone marrow antibody response. An immunocytochemical study during the secondary response in mouse and ratA A Geldof, G F Rimmelzwaan, H L Langevoort
Anticancer Research|July 1, 1986
Direct effects of chemotherapeutic agents on rat prostate tumor clonogenic cellsA A Geldof, B R Rao, H J de Voogt
Urological Research|January 1, 1989
High energy shock waves do not affect either primary tumor growth or metastasis of prostate carcinoma, R3327-MatLyLuA A Geldof, H J De Voogt, B R Rao
Progress in Clinical and Biological Research|January 1, 1989
How to define hormone-resistanceH J de Voogt, R B Rao, A A Geldof
The Prostate|January 1, 1987
Renewal timing of long-acting depot luteinizing hormone-releasing hormone agonist (Zoladex) is critical in the treatment of hormone-dependent rat prostatic carcinoma (R3327-H)A A Geldof, H J de Voogt, B R Rao
Urological Research|January 1, 1987
Development of an in vivo clonogenic cell assay for rat prostate metastatic tumor--R3327-MatLyLuA A Geldof, B R Rao, H J de Voogt
Anticancer Research|August 6, 2000
Cell cycle arrest and clonogenic tumor cell kill by divergent chemotherapeutic drugsS C Mastbergen, I Duivenvoorden, R T Versteegh, et al.
Pageof 5